STAKEHOLDER PERSPECTIVES ON HA GO ADOPTION: A QUALITATIVE STUDY
Author(s)
Junjie Huang, PhD, Chenwen Zhong, PhD, Martin Chi Sang Wong, MD.
The Chinese University of Hong Kong, Hong Kong SAR, China.
The Chinese University of Hong Kong, Hong Kong SAR, China.
OBJECTIVES: The Hospital Authority of Hong Kong developed a mobile application, HA Go, to improve the patient healthcare journey and optimize healthcare resource allocation. This study explores key stakeholders' perceptions of HA Go and identifies barriers and facilitators to its adoption.
METHODS: This qualitative study gathered perspectives from six stakeholder groups in Hong Kong: (1) users, (2) non-users, (3) caregivers, (4) public-sector doctors, (5) private-sector doctors, and (6) policymakers involved in HA Go's development. The Consolidated Framework for Implementation Research (CFIR) guided the interview process and data analysis.
RESULTS: A total of 33 participants were enrolled. Among users, non-users, and caregivers, the primary benefits and facilitators of HA Go use included the usefulness of appointment management (n=11, 73.3%), simplification of healthcare processes (n=9, 60.0%), and ease of access to information and knowledge about HA Go (n=13, 86.7%). Among physicians and policymakers, the key benefits and facilitators identified were improvements in patient appointment systems (n=16, 88.9%), healthcare processes (n=17, 94.4%), and patient medication management (n=13, 72.2%).
CONCLUSIONS: This study highlights HA Go's potential to enhance the patient healthcare journey and optimize healthcare resource allocation, while also identifying key enablers, barriers, and opportunities for improvement. These findings may assist policymakers in developing targeted strategies and enhancements to support the successful implementation of HA Go.
METHODS: This qualitative study gathered perspectives from six stakeholder groups in Hong Kong: (1) users, (2) non-users, (3) caregivers, (4) public-sector doctors, (5) private-sector doctors, and (6) policymakers involved in HA Go's development. The Consolidated Framework for Implementation Research (CFIR) guided the interview process and data analysis.
RESULTS: A total of 33 participants were enrolled. Among users, non-users, and caregivers, the primary benefits and facilitators of HA Go use included the usefulness of appointment management (n=11, 73.3%), simplification of healthcare processes (n=9, 60.0%), and ease of access to information and knowledge about HA Go (n=13, 86.7%). Among physicians and policymakers, the key benefits and facilitators identified were improvements in patient appointment systems (n=16, 88.9%), healthcare processes (n=17, 94.4%), and patient medication management (n=13, 72.2%).
CONCLUSIONS: This study highlights HA Go's potential to enhance the patient healthcare journey and optimize healthcare resource allocation, while also identifying key enablers, barriers, and opportunities for improvement. These findings may assist policymakers in developing targeted strategies and enhancements to support the successful implementation of HA Go.
Conference/Value in Health Info
2026-09, ISPOR Asia Pacific 2026, Bangkok, Thailand
Value in Health, Volume 55, Issue S1
Code
HTA41
Topic
Health Technology Assessment
Topic Subcategory
Decision & Deliberative Processes
Disease
No Additional Disease & Conditions/Specialized Treatment Areas